Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence

Cell Death Dis. 2014 Feb 27;5(2):e1089. doi: 10.1038/cddis.2014.63.

Abstract

Oncogenic stress-induced senescence (OIS) prevents the ability of oncogenic signals to induce tumorigenesis. It is now largely admitted that the mitogenic effect of oncogenes requires metabolic adaptations to respond to new energetic and bio constituent needs. Yet, whether glucose metabolism affects OIS response is largely unknown. This is largely because of the fact that most of the OIS cellular models are cultivated in glucose excess. In this study, we used human epithelial cells, cultivated without glucose excess, to study alteration and functional role of glucose metabolism during OIS. We report a slowdown of glucose uptake and metabolism during OIS. Increasing glucose metabolism by expressing hexokinase2 (HK2), which converts glucose to glucose-6-phosphate (G6P), favors escape from OIS. Inversely, expressing a glucose-6-phosphatase, [corrected] pharmacological inhibition of HK2, or adding nonmetabolizable glucose induced a premature senescence. Manipulations of various metabolites covering G6P downstream pathways (hexosamine, glycolysis, and pentose phosphate pathways) suggest an unexpected role of the hexosamine pathway in controlling OIS. Altogether, our results show that decreased glucose metabolism occurs during and participates to OIS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Cellular Senescence* / drug effects
  • Energy Metabolism* / drug effects
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Epithelial Cells / pathology
  • Female
  • Glucose / metabolism*
  • Glucose-6-Phosphate / metabolism
  • Glycolysis
  • Hexokinase / antagonists & inhibitors
  • Hexokinase / genetics
  • Hexokinase / metabolism
  • Hexosamines / metabolism*
  • Humans
  • Kinetics
  • Mammary Glands, Human / drug effects
  • Mammary Glands, Human / metabolism*
  • Mammary Glands, Human / pathology
  • Oncogenes*
  • Pentose Phosphate Pathway
  • Time Factors
  • Transfection

Substances

  • Enzyme Inhibitors
  • Hexosamines
  • Glucose-6-Phosphate
  • Hexokinase
  • Glucose